[Federal Register Volume 59, Number 236 (Friday, December 9, 1994)]
[Unknown Section]
[Page 0]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 94-30272]
[[Page Unknown]]
[Federal Register: December 9, 1994]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Office of the Secretary
Findings of Scientific Misconduct
AGENCY: Office of the Secretary, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: Notice is hereby given that the Office of Research Integrity
(ORI) has settled misconduct charges in the following case:
John L. Ninnemann, Ph.D. On July 22, 1994, the Office of Research
Integrity (ORI) settled scientific misconduct charges against John L.
Ninnemann, Ph.D., formerly of the University of Utah and the University
of California, San Diego, that will result in his retraction or
correction of several articles related to immunosuppression. Although
Dr. Ninnemann has not admitted guilt to ORI's allegations that he
falsified and misrepresented scientific experiments in grant
applications and publications in the 1970s and 1980s, he has agreed to:
1. Be excluded from eligibility for all federal grants, contracts
and cooperative agreements for three years.
2. Be excluded from serving on any Public Health Service advisory
committees, boards or peer review committees for three years.
3. Submit letters of retraction for five scientific articles.
4. Submit letters of correction for four additional scientific
articles.
Following the settlement, Dr. Ninnemann has submitted the required
letters of correction and retraction and ORI entered the remaining
administrative actions into the PHS ALERT System.
Dr. Ninnemann submitted letters of retraction for the following
five articles.
Ninnemann, J.L., ``Melanoma-Associated Immunosuppression Through B
Cell Activation of Suppressor T Cells,'' Journal of Immunology, 120:
1573-1579 (1978).
Ninnemann, J.L., Stockland, A.E., and Condie, J.T., ``Induction of
Prostaglandin Synthesis-Dependent Suppressor Cells with Endotoxin:
Occurrence in Patients with Thermal Injuries,'' Journal of Clincial
Immunology, 3:142-150 (1983).
Ninnemann, J.L., ``Immunosuppression Following Thermal Injury
through B Cell Activation of Suppressor T Cells,'' Journal of
Trauma, Vol. 20, 3:206-213 (1980).
Ninnemann, J.L., Condie, J.T., Davis, S.E., and Crockett, R.A.,
``Isolation of Immunosuppressive Serum Components Following Thermal
Injury,'' The Journal of Trauma, Vol. 22, 10:837-844 (1982).
Ninnemann, J.L. and Stockland, A.E., ``Participation of
Prostaglandin E Immunosuppression Following Thermal Injury,'' The
Journal of Trauma, Vol. 24, 3:201-7 (1984).
Dr. Ninnemann submitted letters of correction for the following
four articles:
Ninnemann, J.L. Ozkan, A.N. and Sullivan, J.J., ``Hemolysis and
Suppression of Neutrophil Chemotaxis by a Low Molecular Weight
Component of Human Burn Patient Sera,'' Immunology Letters, 10:63-69
(1985).
Ozkan, A.N., and Ninnemann, J.L., ``Reversal of SAP-induced
Immunosuppression and SAP Detection by a Monoclonal Antibody,'' The
Journal of Trauma, Vol. 27, 2:123-6 (1987).
Ninnemann, J.L., and Ozkan, A.N., ``Definition of a Burn Injury-
induced Immunosuppressive Serum Component.'' The Journal of Trauma,
Vol. 25, No. 2:113-7 (1985).
Ninnemann, J.L., and Ozkan, A.N., ``Immunosuppression Activity of
C1Q Degradation Peptides,'' Journal of Trauma, Vol. 27, :119-122
(1987).
FOR FURTHER INFORMATION CONTACT: Director, Division of Research
Investigation, Office of Research Integrity, 301-443-5330.
Lyle W. Bivens,
Director, Office of Research Integrity.
[FR Doc. 94-30272 Filed 12-8-94; 8:45 am]
BILLING CODE 4160-17-M
